Parallel Advisors, LLC Emergent Bio Solutions Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	SELL	$3.17 - $7.91 $104 - $261	-33 Reduced 34.74%	62 $0
Q3 2023 Nov 13, 2023	SELL	$3.17 - $7.91 $104 - $261	-33 Reduced 34.74%	62 $0
Q2 2023 May 20, 2024	BUY	$7.35 - $13.21 $132 - $237	18 Added 23.38%	95 $0
Q2 2023 Aug 04, 2023	BUY	$7.35 - $13.21 $132 - $237	18 Added 23.38%	95 $0
Q1 2023 May 20, 2024	BUY	$7.79 - $16.29 $599 - $1,254	77 New	77 $0
Q4 2022 Feb 03, 2023	BUY	$11.0 - $21.45 $165 - $321	15 Added 24.19%	77 $0
Q3 2022 Nov 10, 2022	BUY	$20.09 - $35.8 $703 - $1,253	35 Added 129.63%	62 $1,000
Q2 2022 Aug 01, 2022	SELL	$27.42 - $43.63 $603 - $959	-22 Reduced 44.9%	27 $1,000
Q1 2022 Apr 28, 2022	SELL	$36.48 - $52.22 $5,581 - $7,989	-153 Reduced 75.74%	49 $2,000
Q4 2021 Jan 20, 2022	BUY	$33.11 - $55.01 $5,827 - $9,681	176 Added 676.92%	202 $9,000
Q3 2021 Nov 02, 2021	SELL	$50.07 - $66.05 $1,201 - $1,585	-24 Reduced 48.0%	26 $1,000
Q2 2021 Aug 06, 2021	BUY	$56.61 - $80.46 $2,547 - $3,620	45 Added 900.0%	50 $3,000
Q1 2021 Apr 23, 2021	SELL	$86.23 - $125.19 $1,379 - $2,003	-16 Reduced 76.19%	5 $0
Q4 2020 Feb 02, 2021	BUY	$79.17 - $111.47 $1,662 - $2,340	21 New	21 $2,000
Q3 2020 Oct 27, 2020	SELL	$81.91 - $134.94 $819 - $1,349	-10 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$54.33 - $89.52 $543 - $895	10 New	10 $0
Q1 2020 Apr 27, 2020	SELL	$49.34 - $68.76 $5,624 - $7,838	-114 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$40.6 - $57.2 $4,628 - $6,520	-114 Reduced 50.0%	114 $6,000
Q4 2018 Feb 05, 2019	SELL	$55.63 - $73.24 $333 - $439	-6 Reduced 2.56%	228 $13,000
Q3 2018 Nov 01, 2018	BUY	$52.05 - $66.51 $12,179 - $15,563	234 New	234 $15,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$33.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$29.9 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21.9 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.6 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.8 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account